Calithera Biosciences is a company that develops small molecule compounds for cancer treatment. They have multiple drugs in clinical trials, including an arginase inhibitor, an IL4I1 inhibitor, and a small molecule inhibitor of CD73. The company has collaborations with Mars, Pfizer, Incyte Corporation, and Antengene Corporation for the research, development, and commercialization of its products.